Lycia Therapeutics (LYCA) Financials: Revenue & Earnings

LYCA price $25.20 -0.91 -3.49%

Ticker
LYCA
Price
$25.20
Change
-0.91 -3.49%
Market cap ?
$1.31B
Sector
Healthcare
Industry
Biotechnology

Fair value

LYCA fair value Not meaningful. Price $25.20.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare LYCA

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
No data yet.

Dividends

Yield —. Payout ratio —. Frequency —.

Safety score 34/100 · At risk. Payout ratio is not reported, so this part stays neutral. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. Yield is unknown, so this part stays neutral.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-27Venrock Healthcare Capital Partners III, L.P.Buy31.07K$26.84833.84K
2026-10-27Venrock Healthcare Capital Partners III, L.P.Buy8.73K$25.84225.56K
2026-10-26Venrock Healthcare Capital Partners III, L.P.Buy8.26K$26.97222.80K
2026-10-26Venrock Healthcare Capital Partners III, L.P.Buy1.94M$18.0035.00M
2026-10-26Venrock Healthcare Capital Partners III, L.P.Buy4.78M——
2026-10-26Venrock Healthcare Capital Partners III, L.P.Sell4.41M——
2026-10-26Venrock Healthcare Capital Partners III, L.P.Sell17.14M——
2026-10-23Venrock Healthcare Capital Partners III, L.P.Buy28.38K$26.11740.98K
2026-10-23Venrock Healthcare Capital Partners III, L.P.Buy24.56K$25.68630.70K
2026-10-22Fischer LaurentBuy20.00K$18.00360.00K
2026-10-22Henderson JaneBuy20.00K$18.00360.00K
2026-10-22RIEFLIN WILLIAM JLBuy20.00K$18.00360.00K
2026-10-22ELI LILLY & CoOther0——
2026-10-22Venrock Healthcare Capital Partners III, L.P.Other3.80M——
2026-10-22Venrock Healthcare Capital Partners III, L.P.Other977.68K——
2026-10-22Bertozzi Carolyn ROther0——
2026-10-22Henderson JaneOther57.67K$3.70213.36K
2026-10-22Versant Ventures VII GP, L.P.Other25.39M——
2026-10-22Versant Ventures VII GP, L.P.Other6.28M——
2026-10-22Fischer LaurentOther0——
2026-10-22Fischer LaurentOther13.31K$2.4432.47K
2026-10-22Fischer LaurentOther13.31K$3.7049.24K
2026-10-22RIEFLIN WILLIAM JLOther0——
2026-10-22RIEFLIN WILLIAM JLOther34.38K$2.4483.88K
2026-10-22RIEFLIN WILLIAM JLOther24.84K$3.7091.91K
2026-10-22Touami SofiaOther169.23K$1.67282.61K
2026-10-22Touami SofiaOther94.26K$2.44230.00K
2026-10-22Touami SofiaOther68.75K$3.70254.39K
2026-10-22Staben StevenOther0——
2026-10-22Staben StevenOther166.34K$1.63271.14K
2026-10-22Staben StevenOther155.25K$2.44378.82K
2026-10-22Staben StevenOther22.18K$2.3552.12K
2026-10-22Staben StevenOther110.90K$3.70410.32K
2026-10-22Lee Chin HyokOther366.40K$2.44894.02K
2026-10-22Lee Chin HyokOther73.19K$3.70270.81K
2026-10-22Bachrodt AmyOther399.75K$3.701.48M
2026-10-22Trombley Aetna WunOther0——
2026-10-22Trombley Aetna WunOther471.25K$1.63768.14K
2026-10-22Trombley Aetna WunOther665.38K$2.441.62M
2026-10-22Trombley Aetna WunOther55.45K$2.35130.30K
2026-10-22Trombley Aetna WunOther443.59K$3.701.64M
2026-08-11Fischer LaurentBuy13.31K$3.7049.24K
2026-08-11Henderson JaneBuy57.67K$3.70213.36K
2026-08-11RIEFLIN WILLIAM JLBuy24.84K$3.7091.91K
2026-08-11Touami SofiaBuy68.75K$3.70254.39K
2026-08-11Staben StevenBuy110.90K$3.70410.32K
2026-08-11Lee Chin HyokBuy73.19K$3.70270.81K
2026-08-11Bachrodt AmyBuy399.75K$3.701.48M
2026-08-11Trombley Aetna WunBuy443.59K$3.701.64M

Institutional holders

HolderSharesChangeChange %Value
No data yet.

Earnings and financials

Lycia Therapeutics Inc. (LYCA) trades at $25.20, with a market cap of $1.31B and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Lycia Therapeutics (LYCA) Financials: Revenue & Earnings

LYCA$25.20-0.91 -3.49%

$1.31B

Market Cap

—

P/E

—

Forward P/E

—

Score

Price History